CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1,234 Cr | ₹-1,293 Cr | ₹-1,200 Cr | ₹-958 Cr | ₹-1,600 Cr |
What is the latest Cash Flow from Financing Activities ratio of CIPLA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-1,234 Cr |
| Mar2025 | ₹-1,293 Cr |
| Mar2024 | ₹-1,200 Cr |
| Mar2023 | ₹-958 Cr |
| Mar2022 | ₹-1,600 Cr |
How is Cash Flow from Financing Activities of CIPLA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,234 Cr | Negative | |
| Mar2025 | ₹-1,293 Cr | Negative | |
| Mar2024 | ₹-1,200 Cr | Negative | |
| Mar2023 | ₹-958 Cr | Negative | |
| Mar2022 | ₹-1,600 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹115,471.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| MANKIND PHARMA | ₹105,107.0 Cr | 0.8% | 8% | 0.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.7% |
4.1% |
-3.6% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses